Ally Bridge Group’s Aptose Biosciences APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-3,131
Closed -$8.42M – 39
2021
Q1
$8.42M Hold
3,131
– – 1.61% 20
2020
Q4
$6.17M Buy
+3,131
New +$7.36M 1.06% 24

Other funds holding APTO

Ally Bridge Group's APTO Position: Q2 2021 in Review

Ally Bridge Group sold out of Aptose Biosciences (APTO) in Q2 2021, closing a stake of 3,131 shares — an estimated $8.42M sold.

Ally Bridge Group first reported a position in APTO in Q4 2020 and held it in 2 quarters. The position peaked at $8.42M in Q1 2021. 63 funds tracked by Wall St. Rank hold APTO as of Q2 2021.

  • Ally Bridge Group reported no remaining Aptose Biosciences position as of Q2 2021 after selling out during the quarter.
  • Ally Bridge Group sold 3,131 Aptose Biosciences shares in Q2 2021, an estimated $8.42M.
  • Ally Bridge Group first reported a position in Aptose Biosciences in Q4 2020 and held it in 2 quarters.
  • Ally Bridge Group's Aptose Biosciences position peaked at $8.42M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Aptose Biosciences as of Q2 2021.

Based on Ally Bridge Group's 13F filing for Q2 2021, filed 16 Aug 2021.